Kathryn M. Lemberg
Pediatrics | Oncology
1800 Orleans Street, Bloomberg 11N
Bloomberg 11N
Baltimore, MD 21287
Bloomberg 11N
Baltimore, MD 21287
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
A Framework for Prioritizing Novel Agents in Malignant Peripheral Nerve Sheath Tumor Trials: A report from the Neurofibromatosis Clinical Trials Consortium.
Journal: Neuro-oncology
Published: May 13, 2026
Outcomes Associated with Radiation Therapy for Localized Resectable Malignant Peripheral Nerve Sheath Tumors.
Journal: Advances in radiation oncology
Published: October 31, 2025
Comparison of Presentation and Management in Skeletal and Extraskeletal Ewing Sarcoma in Children.
Journal: Journal of surgical oncology
Published: May 16, 2025
Brain Metastasis in Pediatric Patients with Osteosarcoma.
Journal: Current oncology (Toronto, Ont.)
Published: September 30, 2024
Anthropometric measurements of children with neurofibromatosis type I: impact of plexiform neurofibroma volume and treatment.
Journal: Pediatric research
Published: February 15, 2024
Analysis of treatment sequence and outcomes in patients with relapsed malignant peripheral nerve sheath tumors.
Journal: Neuro-oncology advances
Published: December 22, 2023
Liver transplant for primary biliary tract neuroendocrine tumor in a nine-year-old girl.
Journal: Pediatric transplantation
Published: May 18, 2023
Pro-905, a Novel Purine Antimetabolite, Combines with Glutamine Amidotransferase Inhibition to Suppress Growth of Malignant Peripheral Nerve Sheath Tumor.
Journal: Molecular cancer therapeutics
Published: April 27, 2023
Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug.
Journal: Science advances
Published: November 16, 2022
Clinical development of metabolic inhibitors for oncology.
Journal: The Journal of clinical investigation
Published: January 04, 2022
Last Updated: 09/26/2026